[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 1970


Author Affiliations

University of Alabama in Birmingham, the Medical Center 1919 Seventh Ave S Birmingham, Ala 35233

Arch Dermatol. 1970;102(6):694. doi:10.1001/archderm.1970.04000120112022

To the Editor.—  In regard to the report by Leavell and Yarbro of "Hydroxyurea: A New Treatment for Psoriasis" (Arch Derm 102:144-150, 1970), I was disappointed that they did not make specific reference to some of the studies of other cytotoxic agents in the treatment of psoriasis. Purine analogues,1-3 alkylating agents2,3 and other antimetabolites4 have been reported to be effective in psoriasis. Thus, the question is whether hydroxyurea has a better therapeutic index and less side effects in the treatment of psoriasis compared with these other cytotoxic drugs. A comparison study would be of interest. I share the feeling of the authors that there may be better, safer drugs than methotrexate in severe psoriasis.

First Page Preview View Large
First page PDF preview
First page PDF preview